The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Top Cited Papers
- 15 November 2005
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 143 (10) , 722-728
- https://doi.org/10.7326/0003-4819-143-10-200511150-00009
Abstract
The frequent association of nonalcoholic fatty liver disease with components of the metabolic syndrome such as obesity, hyperglycemia, dyslipidemia, and hypertension is well known. However, no prospective study has examined the role of the metabolic syndrome in the development of this disease. To characterize the longitudinal relationship between the metabolic syndrome and nonalcoholic fatty liver disease. A prospective observational study. A medical health checkup program in a general hospital. 4401 apparently healthy Japanese men and women, 21 to 80 years of age, with a mean body mass index (BMI) of 22.6 kg/m2 (SD, 3.0). Alcohol intake was assessed by using a questionnaire. Biochemical tests for liver and metabolic function and abdominal ultrasonography were done. Modified criteria of the National Cholesterol Education Program Adult Treatment Panel III were used to characterize the metabolic syndrome. At baseline, 812 of 4401 (18%) participants had nonalcoholic fatty liver disease. During the mean follow-up period of 414 days (SD, 128), the authors observed 308 new cases (10%) of nonalcoholic fatty liver disease among 3147 participants who were disease-free at baseline and who completed a second examination. Regression of nonalcoholic fatty liver disease was found in 113 (16%) of 704 participants who had the disease at baseline and who completed a second examination. Men and women who met the criteria for the metabolic syndrome at baseline were more likely to develop the disease during follow-up (adjusted odds ratio, 4.00 [95% CI, 2.63 to 6.08] and 11.20 [CI, 4.85 to 25.87], respectively). Nonalcoholic fatty liver disease was less likely to regress in those participants with the metabolic syndrome at baseline. Ultrasonography may lead to an incorrect diagnosis of nonalcoholic fatty liver disease in 10% to 30% of cases and cannot distinguish steatohepatitis from simple steatosis. Self-reported alcohol intake may cause bias. Because all of the participants were Japanese, generalizability to non-Japanese populations is uncertain. The metabolic syndrome is a strong predictor of nonalcoholic fatty liver disease.Keywords
This publication has 23 references indexed in Scilit:
- Increasing Prevalence of the Metabolic Syndrome Among U.S. AdultsDiabetes Care, 2004
- The clinical features, diagnosis and natural history of nonalcoholic fatty liver diseaseClinics in Liver Disease, 2004
- Non‐alcoholic steatohepatitis in type 2 diabetes mellitusJournal of Gastroenterology and Hepatology, 2004
- Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistanceGut, 2004
- Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock?Journal of Gastroenterology and Hepatology, 2004
- Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical backgroundThe Esophagus, 2003
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceHepatology, 2003
- AGA technical review on nonalcoholic fatty liver diseaseGastroenterology, 2002
- Fatty Infiltration of Liver in Hyperlipidemic PatientsDigestive Diseases and Sciences, 2000
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988